BNTX logo

BioNTech SE (BNTX)

Profile

Full Name

BioNTech SE

Ticker Symbol

BNTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

October 10, 2019

Indexes

Not included

Website

http://www.biontech.de

Employees

6772

Key Details

Price

$97.53(-1.04%)

Market cap

Last Dividend

$2.13

TTM Dividend yield

-

Annual revenue

$2.98B(-27.98% YoY)

Annual EPS

-$3.00(-172.31% YoY)

PE ratio

-

Next earnings date

Aug 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $97.53
    BNTX price is $97.53

    30-Day Relative Volume

    0.42
    BNTX 30-day relative volume is 0.42

    Price Performance

    Price Most recent change

    -1.04%
    BNTX price was down -1.04% on May 28, 2025

    Price YTD change

    -14.41%
    BNTX price is down -14.41% since January 1st

    Price 1-year change

    +4.61%
    BNTX price is up +4.61% year-on-year

    Price 3-year change

    -41.58%
    BNTX price is down -41.58% over the past 3 years

    Price Range

    Price All-time high

    $464.00
    BNTX price is currently -78.98% below its historical high of $464.00

    Price 3-year low

    $76.53
    BNTX price is currently +27.44% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $23.45B
    BNTX market capitalization is $23.45 billion

    Market cap 3-year change

    -42.63%
    BNTX market capitalization is down -42.63% over the past 3 years

    Market cap All-time high

    $108.46B
    BNTX market capitalization is currently -78.38% below its historical high of $108.46 billion

    Market cap sector rank

    95.91%
    BNTX market capitalization is higher than 95.91% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.25%
    BNTX shares outstanding is down -0.25% year-on-year

    Shares Outstanding 3-Year Change

    -1.79%
    BNTX shares outstanding is down -1.79% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.90
    BNTX beta is 0.90

    200-day SMA

    $107.50
    BNTX price is currently -9.28% below its 200-day simple moving average

    50-day SMA

    $97.70
    BNTX price is currently -0.18% below its 50-day simple moving average

    RSI

    48.76
    BNTX 14-day relative strength index is 48.76

    Volume

    0.42
    BNTX 30-day relative volume is 0.42

    ATR

    $3.66
    BNTX average true range is $3.66

    10-day Historical Volatility

    40.67%
    BNTX 10-day historical volatility is 40.67%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $2.13
    BNTX last dividend was $2.13 per share, with an ex-dividend date of June 2, 2022

    Next Dividend

    -
    BNTX next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    BNTX annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    BNTX annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    BNTX annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    BNTX annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    BNTX annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    BNTX annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    BNTX annual payout ratio is 0.00%

    Dividends paid

    $0.00
    BNTX annual dividends paid is $0.00

    Free cash flow

    -$264.74M
    BNTX annual free cash flow is -$264.74 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.98B
    BNTX annual revenue is $2.98 billion

    Revenue Analysts estimate

    $2.03B
    BNTX annual revenue is currently +46.85% higher than the consensus analysts' forecast

    Revenue 1-year change

    -27.98%
    BNTX annual revenue is down -27.98% year-on-year

    Revenue Sector rank

    88.42%
    BNTX annual revenue is higher than 88.42% of companies in Healthcare sector

    EPS

    EPS

    -$3.00
    BNTX annual earnings per share is -$3.00

    EPS Analysts estimate

    -$5.49
    BNTX annual earnings per share is currently -45.39% lower than the consensus analysts' forecast

    EPS 1-year change

    -172.31%
    BNTX annual earnings per share is down -172.31% year-on-year

    EPS Sector rank

    28.94%
    BNTX annual earnings per share is higher than 28.94% of companies in Healthcare sector

    Profit

    Gross profit

    $2.39B
    BNTX annual gross profit is $2.39 billion

    Gross margin

    80.32%
    BNTX annual gross profit margin is 80.32%

    Operating profit

    -$644.76M
    BNTX annual operating income is -$644.76 million

    Operating margin

    -21.65%
    BNTX annual operating profit margin is -21.65%

    Net income

    -$720.09M
    BNTX annual net profit is -$720.09 million

    Net margin

    -24.18%
    BNTX annual net profit margin is -24.18%

    Expenses

    Total expenses

    $3.62B
    BNTX annual total expenses is $3.62 billion

    Operating expenses

    $3.04B
    BNTX annual total operating expenses is $3.04 billion

    Cost of goods sold

    $585.88M
    BNTX annual cost of goods sold is $585.88 million

    Selling, general & administrative expenses

    $648.33M
    BNTX annual SGA is $648.33 million

    Depreciation and amortization

    $322.54M
    BNTX annual depreciation & amortization is $322.54 million

    Interest expense

    $13.64M
    BNTX annual interest expense is $13.64 million

    Income tax

    -$13.42M
    BNTX annual income tax is -$13.42 million

    EBIT & EBITDA

    EBIT

    -$719.87M
    BNTX annual earnings before interest & taxes is -$719.87 million

    EBITDA

    -$397.33M
    BNTX annual EBITDA is -$397.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $23.44B
    BNTX annual total assets is $23.44 billion

    Non current assets

    $3.88B
    BNTX annual long term assets is $3.88 billion

    Current assets

    $19.57B
    BNTX annual total current assets is $19.57 billion

    Cash and cash equivalents

    $10.16B
    BNTX annual cash & cash equivalents is $10.16 billion

    Accounts receivable

    $1.52B
    BNTX annual accounts receivable is $1.52 billion

    Inventory

    $294.79M
    BNTX annual inventory is $294.79 million

    Liabilities

    Total liabilities

    $3.25B
    BNTX annual total liabilities is $3.25 billion

    Long term liabilities

    $619.56M
    BNTX annual total long term liabilities is $619.56 million

    Current liabilities

    $2.63B
    BNTX annual total current liabilities is $2.63 billion

    Accounts payable

    $444.01M
    BNTX annual accounts payable is $444.01 million

    Debt

    Total debt

    $264.51M
    BNTX annual total debt is $264.51 million

    Total debt 1-year change

    +9.22%
    BNTX annual total debt is up +9.22% year-on-year

    Long term debt

    $223.41M
    BNTX annual long term debt is $223.41 million

    Short term debt

    $41.10M
    BNTX annual short term debt is $41.10 million

    Equity & Capital

    Shareholders equity

    $20.20B
    BNTX annual stockholders equity is $20.20 billion

    Book value

    $20.20B
    BNTX annual book value is $20.20 billion

    Retained earnings

    $19.87B
    BNTX annual retained earnings is $19.87 billion

    Working capital

    $16.94B
    BNTX annual working capital is $16.94 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $224.80M
    BNTX annual cash flow from operations is $224.80 million

    Cash from operations 1-year change

    -96.13%
    BNTX annual cash flow from operations is down -96.13% year-on-year

    Cash from investing

    -$2.25B
    BNTX annual cash flow from investing activities is -$2.25 billion

    Cash from investing 1-year change

    +70.08%
    BNTX annual cash flow from investing activities is up +70.08% year-on-year

    Cash from financing

    -$49.68M
    BNTX annual cash flow from financing activities is -$49.68 million

    Cash from financing 1-year change

    +94.11%
    BNTX annual cash flow from financing activities is up +94.11% year-on-year

    CAPEX

    CAPEX

    $489.55M
    BNTX annual capital expenditures is $489.55 million

    CAPEX 1-year change

    -35.9%
    BNTX annual capital expenditures is down -35.9% year-on-year

    Free Cash Flow

    Free cash flow

    -$264.74M
    BNTX annual free cash flow is -$264.74 million

    Free cash flow 1-year change

    -105.24%
    BNTX annual free cash flow is down -105.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    80.32%
    BNTX annual gross profit margin is 80.32%

    Operating margin

    -21.65%
    BNTX annual operating profit margin is -21.65%

    Net margin

    -24.18%
    BNTX annual net profit margin is -24.18%

    ROA & ROE

    ROA

    -2.95%
    BNTX annual return on assets is -2.95%

    ROE

    -3.38%
    BNTX annual return on equity is -3.38%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BNTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BNTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.14
    BNTX price to book ratio is 1.14

    PB ratio Sector rank

    44.79%
    BNTX price to book ratio is higher than 44.79% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.90
    BNTX price to sales ratio is 7.90

    PS ratio Sector rank

    74.24%
    BNTX price to sales ratio is higher than 74.24% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $12.74B
    BNTX enterprise value is $12.74 billion

    Enterprise value Sector rank

    93.31%
    BNTX enterprise value is higher than 93.31% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -27.29
    BNTX EV/EBITDA is -27.29

    EV/EBITDA Sector rank

    5.67%
    BNTX EV/EBITDA is higher than 5.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.45
    BNTX annual current ratio is 7.45

    Quick ratio

    7.34
    BNTX annual quick ratio is 7.34

    Leverage

    Debt to equity

    0.01
    BNTX annual debt to equity ratio is 0.01

    Interest coverage ratio

    -52.79
    BNTX annual interest coverage ratio is -52.79

    Risk & Stability

    Piotroski F-Score

    1
    BNTX piotroski f-score is 1

    Altman Z-Score

    6.41
    BNTX altman z-score is 6.41

    Analyst ratings

    Recent major analysts updates

    May 22, 25 JP Morgan
    Neutral
    May 22, 25 HC Wainwright & Co.
    Buy
    May 14, 25 HC Wainwright & Co.
    Buy
    May 6, 25 Morgan Stanley
    Overweight
    May 6, 25 Citigroup
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Mar 13, 25 Citigroup
    Buy
    Mar 11, 25 Morgan Stanley
    Overweight
    Mar 11, 25 Canaccord Genuity
    Buy
    Mar 11, 25 BMO Capital
    Outperform

    Institutional Ownership

    Screeners with BNTX included

    Stocks below SMA 200
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    High Altman Z score stocks
    NASDAQ Listed Companies
    Companies with buyback
    Biotechnology industry
    Ex Dividend dates calendar
    • What is the ticker symbol for BioNTech SE?
    • Does BioNTech SE pay dividends?
    • What sector is BioNTech SE in?
    • What industry is BioNTech SE in?
    • What country is BioNTech SE based in?
    • When did BioNTech SE go public?
    • Is BioNTech SE in the S&P 500?
    • Is BioNTech SE in the NASDAQ 100?
    • Is BioNTech SE in the Dow Jones?
    • When was BioNTech SE's last earnings report?
    • When does BioNTech SE report earnings?

    What is the ticker symbol for BioNTech SE?

    The ticker symbol for BioNTech SE is NASDAQ:BNTX

    Does BioNTech SE pay dividends?

    No, BioNTech SE does not pay dividends

    What sector is BioNTech SE in?

    BioNTech SE is in the Healthcare sector

    What industry is BioNTech SE in?

    BioNTech SE is in the Biotechnology industry

    What country is BioNTech SE based in?

    BioNTech SE is headquartered in Germany

    When did BioNTech SE go public?

    BioNTech SE's initial public offering (IPO) was on October 10, 2019

    Is BioNTech SE in the S&P 500?

    No, BioNTech SE is not included in the S&P 500 index

    Is BioNTech SE in the NASDAQ 100?

    No, BioNTech SE is not included in the NASDAQ 100 index

    Is BioNTech SE in the Dow Jones?

    No, BioNTech SE is not included in the Dow Jones index

    When was BioNTech SE's last earnings report?

    BioNTech SE's most recent earnings report was on May 5, 2025

    When does BioNTech SE report earnings?

    The next expected earnings date for BioNTech SE is Aug 4, 2025
    On this page